Vantage Consulting Group Inc Dexcom Inc Transaction History
Vantage Consulting Group Inc
- $9.74 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,071Shares Held
354MCall Options Held
5.56MPut Options Held
5.71M-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.95 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.06 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$1.01 Billion0.06% of portfolio
-
Baillie Gifford & CO15.9MShares$948 Million0.84% of portfolio
-
Geode Capital Management, LLC Boston, MA11MShares$655 Million0.05% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $23.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...